Verve Therapeutics, Inc. (NASDAQ:VERV) is one of the Stocks With Huge Catalysts on the Horizon. On April 14, Verve ...

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc.

Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.

Eli Lilly and Company has acquired Verve Therapeutics Inc., a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...

Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Verve's common ...

Verve Therapeutics ( (VERV)) has shared an announcement. Verve Therapeutics announced the establishment of a retention bonus program for its employees, granting significant retention awards to key ...

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics ...

Verve Therapeutics , Inc. (NASDAQ:VERV), whose stock has surged over 100% in the past six months according to InvestingPro data, announced Monday that it has established a retention bonus program ...

Verve Therapeutics , Inc. (NASDAQ: VERV), whose stock has surged over 100% in the past six months according to InvestingPro data, announced Monday that it has established a retention bonus program for ...

The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...